Amerise Biosciences Ltd — Others, 25-08-2025: Others

Amerise Biosciences has released its Annual Report for the financial year 2024-25. The company reported a net profit of 0.0057 crore, a turnaround from a loss in the prior year, despite not generating revenue from operations. Its 40th Annual General Meeting will consider adopting these financial statements. Shareholders will also vote on re-appointing Director Dinesh Rathod and the statutory auditors. Key proposals include appointing Kelash Bunkar as an Independent Director and significantly increasing borrowing limits and investment/loan/guarantee limits, each up to 100 crore, to support future business expansion.